Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,120
-80 (-0.61%)
At close: Jun 5, 2025, 3:30 PM KST
-2.16%
Market Cap 235.78B
Revenue (ttm) 272.12B
Net Income (ttm) 11.45B
Shares Out 17.97M
EPS (ttm) 630.29
PE Ratio 20.82
Forward PE n/a
Dividend 150.00 (1.14%)
Ex-Dividend Date Dec 27, 2024
Volume 48,493
Average Volume 68,108
Open 13,200
Previous Close 13,200
Day's Range 13,070 - 13,230
52-Week Range 9,540 - 15,550
Beta 0.68
RSI 60.56
Earnings Date May 14, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 670
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.